(Reuters) -Weight-loss drug developer Metsera has raised $275 million after pricing its U.S. initial public offering at $18 per share, above its targeted range, the ARCH Venture Partners-backed ...

Dr. Agarwal's Health Care Ltd has launched its IPO, offering a great investment opportunity. The IPO size stands at ₹3,027.26 ...

Malpani Pipes and Fittings Limited has announced its IPO with an offering size of ₹25.92 crore, including a fresh issue of 28.80 lakh shares. The IPO will be open for subscription from January 29, ...

The move seeks to leverage the wealth of information available with the ministry of corporate affairs from various statutory filings by companies and limited liability partnerships.

A pair of drugmakers priced their initial public offerings on Thursday, delivering the best month for US health care ...

French AI startup Mistral unveils a breakthrough 24B parameter language model that matches the performance of models three ...

TMTG announced its expansion into financial services and fintech amidst a backdrop of an administration favoring ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that could make the kidney disease drug developer the first U.S. biotech ...

Gaming mergers and acquisitions (M&A) and financings in 2024 grew 39% to $27.3 billion in disclosed deal value across over 967 transactions, according to a report by Drake Star Partners. That’s a ...

Private equity-backed oil and natural gas producer Infinity Natural Resources on Thursday raised $265 million in its initial ...

Twin Peaks, a sports bar chain, made its debut on the Nasdaq Thursday, marking the first restaurant IPO of 2025.

The private equity owner of Silvus Technologies is exploring options for the mobile communications provider, including a sale ...